期刊文献+

中性粒细胞明胶酶相关脂质运载蛋白对轻中度肾衰竭患者对比剂急性肾损伤的预测价值 被引量:13

Prediction of plasma neutrophil gelatinase-associated lipocalin for contrast induced acute kidney injury
下载PDF
导出
摘要 目的:评价血浆中性粒细胞明胶酶相关脂质运载蛋白(neutrophil gelatinase-associated li-pocalin,NGAL)在对比剂急性肾损害(contrast induced acute kidney injury,CIAKI)早期诊断价值。方法:连续入选拟行冠状动脉造影及支架植入术的患者。包括稳定型心绞痛及除急性ST段抬高性心肌梗死外的急性冠状动脉综合征患者;按照适合中国人的肾脏疾病饮食调整公式(Modified diet in renal dis-ease,MDRD)公式评价肾功能,选择30≤eGFR<90 mL.min-1.1.73 m-2的患者。CIAKI定义为:PCI术后48~72 h,SCr升高44.2 mmol/L(0.5 mg/dL)或升高25%。术前及术后4 h血浆NGAL采用ELISA方法检测,评价NGAL对CIAKI的预测价值。结果:共入选患者311例,其中39例(12.5%)患者发生了CIAKI。术前及术后4 h血浆NGAL水平的曲线下面积(area under the ROC curve,AUC)分别为(0.567,95%CI:0.465~0.668,P=0.210)和(0.662,95%CI:0.565~0.758,P=0.002)。结论:血浆NGAL可以作为CIAKI的早期诊断标志物,阴性诊断价值更大。 Objective:To evaluate the Neutrophil Gelatinase-Associated Lipocalin(NGAL) for early prediction of Contrast Induced Acute Kidney Injury(CIAKI).Methods: The patients with established or suspected coronary artery disease were continuously enrolled in our study.The estimated glomerular filtration rate(eGFR) was more than 30 mL/min/1.73 m2 and nor more than 90 mL/min/1.73 m2 according to the formula of modified diet in renal disease(MDRD).The blood was obtained before and 4 hours after procedure for the plasma NGAL measure used ELISA kit.CIAKI was defined as a relative increase in serum creatinine(SCr) from baseline of≥25% or an absolute increase of≥0.5 mg/dL(44 μmol/L) up to day 3.Results: Total of 311 patients was enrolled,among whom 39(12.5%) developed CIAKI.The area under the ROC curve(AUC) of plasma NGAL was 0.567(0.465-0.668,P=0.210)and 0.662(95%CI: 0.565-0.758,P=0.002)before and after procedure,respectively.The negative predictive value was more than 90%.Conclusion: Plasma NGAL might be useful biomarker for prediction of CIAKI with higher negative predictive value.
出处 《心肺血管病杂志》 CAS 2011年第4期280-283,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 急性肾损伤 中性粒细胞明胶酶相关脂质运载蛋白 心脏疾病 对比剂 Neutrophil gelatinase-associated lipocalin Contrast Acute kidney injury Heart disease
  • 相关文献

参考文献14

  • 1Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficien- cy. Am J Kidney Dis, 2002, 39: 930-936.
  • 2Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006, 17 : 2937-2944.
  • 3McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006, 98: 5K-13K.
  • 4Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol, 2004, 44: 1393-1399.
  • 5周力,陈晖,张侃,李虹伟.维生素C预防对比剂肾病的临床研究[J].心肺血管病杂志,2010,29(S1):88-88. 被引量:5
  • 6李榕彬,梅荣,盖鲁粤.老年冠心病合并糖尿病患者造影剂肾脏损害预防性护理的研究[J].心肺血管病杂志,2010,29(S1):38-41. 被引量:3
  • 7Solomon R, Barrett B. Follow-up of patients with contrast-in- duced nephropathy. Kidney Int Suppl, 2006, 100: S46-50.
  • 8Tomlanovich S, Golbetz H, Perlroth M, et al. Limitations of cre- atinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis, 1986, 8: 332-337.
  • 9Star RA. Treatment of acute renal failure. Kidney Int, 1998, 54: 1817-1831.
  • 10Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int, 2003, 63: 1714-1724.

二级参考文献7

共引文献6

同被引文献159

  • 1李榕彬,梅荣,盖鲁粤.老年冠心病合并糖尿病患者造影剂肾脏损害预防性护理的研究[J].心肺血管病杂志,2010,29(S1):38-41. 被引量:3
  • 2周力,陈晖,张侃,李虹伟.维生素C预防对比剂肾病的临床研究[J].心肺血管病杂志,2010,29(S1):88-88. 被引量:5
  • 3宫春勇.铜蓝蛋白及其临床应用[J].医学综述,2006,12(13):823-825. 被引量:19
  • 4Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficien- cy. Am J Kidney Dis, 2002,39:930-936.
  • 5Gupta R, Bimbaum Y, Uretsky BF. The renal patient with coro- nary artery disease. Current concepts and dilemmas. J Am Coll Cardiol, 2004,44 : 1343-1353.
  • 6Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal fail- ure on mortality: a cohort analysis. JAMA, 1996,275: 1489- 1494.
  • 7McCullough PA. Acute kidney injury with iodinated contrast. Crit Care Med, 2008,36 : S204-11.
  • 8Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreat- ment to prevent contrast-induced nephmpathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol, 2008, 101:279-85.
  • 9Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in pereutaneous coronary intervention. Circula- tion, 2001,104:992-997.
  • 10Park DW, Yun SC, Lee JY, et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-elu- ting stent implantation. Circulation, 2009,120 : 1987-1995.

引证文献13

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部